Results 261 to 270 of about 1,157,850 (339)
Association of relative fat mass with asthma: inflammatory markers as potential mediators. [PDF]
Zhou M+5 more
europepmc +1 more source
Fat mass but not muscle mass linked to OA risk [PDF]
openaire +2 more sources
METTL14/IGF2BP2‐mediated m6A modification drives LINC01094 upregulation in BC. Then, LINC01094 interacts with PKM2 monomers to promote their dimerization, while serving as a flexible scaffold to facilitate the assembly of the PKM2/JMJD5 complex, synergistically stabilizing PKM2 dimers and enhancing their nuclear translocation.
Mengqi Wang+8 more
wiley +1 more source
Dietary sulfur amino acid restriction improves metabolic health by reducing fat mass. [PDF]
Xin C+14 more
europepmc +1 more source
This study constructs a stacked multimodal machine learning model for nonalcoholic fattly liver disease (NAFLD) by integrating genetic and clinical features, and synthesize an in‐silico quantitative marker (ISNLD) that enables personalized risk stratification for intrahepatic and extrahepatic outcomes of high‐risk individuals of NAFLD.
Lushan Xiao+14 more
wiley +1 more source
Association between relative fat mass and female infertility among reproductive-aged women from NHANES 2013-2020. [PDF]
Chen Y, Li Y, Zhang B, Xia W, Feng X.
europepmc +1 more source
This study identifies alnustone, a natural compound from Alpinia katsumadai, as a potent therapeutic agent for MASLD and MASH. Alnustone enhances mitochondrial fatty acid β‐oxidation by directly targeting calmodulin, improving liver steatosis, fibrosis, and insulin resistance in vivo.
Shourui Hu+13 more
wiley +1 more source
The association between relative fat mass (RFM) and lumbar bone density in US adults: Insight from 2011-2018 NHANES. [PDF]
Zhang H, Mei J.
europepmc +1 more source
These findings elucidate the innovative role of HIC1 as a transcriptional activator in GC, driving the initiation of pyroptosis and enhancing CD8+ T cell infiltration, which has certain novelty and creative significance. Collectively, targeting HIC1 can present an appealing immunotherapeutic strategy to improve outcomes in GC patients.
Mengjie Kang+4 more
wiley +1 more source